KIF1B and neuroblastoma: Interestingly, high expression levels of ALCAM, CACNA2D3, DST, EPB41L4A or KIF1B were not only associated with the prognosis of MYCN non-amplified neuroblastoma patients, but also were associated with the prognosis of all neuroblastoma patients.